March 7, 2016

Introducing Bert Vrijhoef as our new CIO!

As of March 2015, we are delighted to welcome Prof. dr. Bert Vrijhoef as the Chief Innovation Officer (CIO) of […]
February 17, 2016

Three take home messages from the Economic Evaluation presentation

The new Dutch economic evaluation guideline was presented yesterday. Panaxea attended this meeting to be aware of this new guideline, […]
February 10, 2016

The new Dutch economic evaluation guideline

All parties in health care, from governments to hospitals, are bound to budgets. The use of economic evaluations helps these […]
February 2, 2016

Panaxea takes place in CRADL consortium

Panaxea is proud to announce that it takes place in this consortium with 11 other parties, like the Middlesex University […]
November 9, 2015

Panaxea posters, presentations and workshops @ISPOR Milan 9-11 November 2015

Dear ISPORIAN, Panaxea (www.panaxea.eu) provides customized, high-quality analyses about the added value of products and interventions in the care pathway. […]
May 19, 2015

Health economic evaluation of a strict glucose control guideline implemented using point-of-care testing in three Intensive Care Units in the Netherlands

Health economic evaluation of a strict glucose control guideline implemented using point-of-care testing in three Intensive Care Units in the […]
May 19, 2015

Generic decision model for diagnostic tests

To give (potential) clients a preliminary insight in the cost-effectiveness of their diagnostic test, we developed an online generic decision […]
May 19, 2015

Marloes van der Maas joined board “Jong NVTAG”

Jong NVTAG is a Dutch organization that aims to address the need of young professionals in the field of health […]
April 20, 2015

Long-term cost–effectiveness of Oncotype DX® versus current clinical practice from a Dutch cost perspective

Michelle Kip, Helma Monteban & Lotte Steuten, Long-term cost–effectiveness of Oncotype DX® versus current clinical practice from a Dutch cost […]